Back to 
BlackRock Finance, Inc.
BlackRock Finance, Inc.
SRPT
3 quarters
Position history for BlackRock Finance, Inc.'s holdings in Sarepta Therapeutics, Inc.
As of its last 13F, for Q2 2024, BlackRock Finance held 10,324,404 shares of SRPT (Sarepta Therapeutics), worth $1.6B. It increased the position by 4,364,034 shares (+73.2%) from Q1 2024. BlackRock Finance held SRPT from Q4 2023 to Q2 2024, across 3 quarterly 13F filings.
Current Value
$1.6B
Current Shares
10.3M
Total Value Change
+$1B
Total Shares Change
+4.1M
Quarter-by-Quarter History
Other major holders of SRPT: BlackRock, Inc., Capital Research Global Investors, FMR LLC, Vanguard Group Inc.